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EFFECTS ON OTHER LEUKOCYTES 
Evaluation of the Influence of FK 506, Rapamycin, and Cyclosporine on 
'Processing and Presentation of Particulate Antigen by Macrophages: 
, Assessment of a Drug "Carry-Over" Effect 
M.H. Cooper, S.H. Gregory, A.W. Thomson, J.J. Fung, T.E. Starzl, and E.J. Wing 
.' FK 506 is 10 to 100 times more potent than cyclosporine 
(CyA) in inhibiting T-cell responses to mitogenic and 
allostimulatory signals in vitro.) Both drugs affect the early 
events subsequent to antigen-T-cell receptor interaction 
that characterizes T-cell activation.) In contrast, rapamy-
cin, which is structurally similar to FK 506, inhibits 
cytokine-mediated, but not T-cell receptor-mediated acti-
vation.) The processing and presentation of antigen by 
macrophages is integral to the early events of T-cell 
activation. A recent report indicates that Cy A interferes 
with these macrophage functions. 2 In view of this obser-
vation, we examined the effects of FK 506 and rapamycin 
on the processing and presentation of particulate antigen 
usirig a model composed of bone marrow-derived macro-
:" phages, heat-killed Listeria monocytogenes (HKLM), and 
a listerial-reactive CD4+ T-cell clone. 
< 
.'(: MATERIALS AND METHODS 
~: 
Animals 
Eight- to 12-week-old female C57BLl6J mice purchased from 
JacksonLaboratories, Bar Harbor. Me, were used in all experi-
ments. The animals were housed in accordance with the guide· 
lines proposed by the Institute of Laboratory Animals Resources. 
National Research Council. 
Bone Marrow-Derived Macrophages 
Murine bone marrow-derived macrophages were generated in the 
presence of L-cell-<:onditioned medium as previously reported. 3 
Cells harvested from day 11 cultures were used for the experi-
ments described. 
4i Bacteria 
The culture and maintenance of L monocytogenes (EGD strain) 
have been reported previously.4 HKLM was prepared by incu-
bating bacterial suspensions for 1 hour at 60°C. HKLM was 
washed twice, suspended in saline at 1 x 109 cells/mL, and frozen 
_' at -80°C until required. 
CD4+ T-Cell Clone 
~ The production and characterization of the Listeria-specific T-cell 
:;;' clone 5A9 have been previously described. S Viable cells were 
¥ purified by Picoll-H ypaque centrifugation prior to use. 
if)· 
Immunosuppressants 
FK 506 was a gift from Fujisawa Pharmaceutical Company Ltd. 
Osaka. Japan. Rapamycin was a gift from Wyeth-Ayerst Labora-
tories. Princeton, NJ. CyA was purchased from Sandoz Pharma-
ceuticals, Basel, Switzerland. All drugs were obtained in pure 
powder form. Ten millimolar stock solutions were prepared in 
absolute ethanol. All subsequent dilutions were made in tissue 
culture medium (RPMI-I640). 
Experimental Assay of Antigen Processing and Presentation 
Bone marrow-derived macrophages (3 x 104 cells/well) were 
seeded into 96-well microtiter plates and incubated for 2 hours at 
37°C in order to allow the cells to attach. PK 506, rapamycin. or 
Cy A was added and the cells were incubated for an additional 2 
hours. The cell monolayer was then washed four times according 
to a protocol considered adequate for the removal of CyA.6 One 
million HKLM and 3 x lOs 5A9 T lymphocytes suspended in 
RPMI-I640 supplemented with 10% heat-inactivated fetal bovine 
serum, 1 mmoVL sodium pyruvate, 1 mmollL L-glutamine, 1% 
essential and nonessential amino acids (M.A. Bioproducts, Walk-
erville. Md), 5 x lO-s M 2-mercaptoethanol, and 1% penicillin! 
streptomycinlfungizone (Gibco, Grand Island, NY) were added to 
each well and the cells were cocultured for 3 days. To assess 
T-cell proliferation, each well received I /-LCi of tritiated thymidine 
during the last 18 hours of the culture period and the counts 
incorporated were determined by liquid scintillation counting. 
Concanavalin A Stimulation of Normal Splenocytes 
Normal mouse splenocytes (1 x lOs cells per well) and 2 /-Lg/mL of 
concanavalin A (ConA) (Sigma Chemicals, St Louis, Mo) were 
added to cultures of drug-treated macrophages. Splenocyte pro-
liferation was assessed by tritiated thymidine incorporation on 
day 3. 
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Fig 1. Antigen-specific T-cell proliferation is suppressed in co-
cultures containing macrophages pretreated with FK 506, CyA, or 
rapamycin. 5A9 T lymphocytes and HKLM were cocultured for 3 
days with bone marrow-derived macrophages pretreated with drug 
at the concentrations indicated. Cell proliferation was assessed by 
tritiated thymidine incorporation during the last 18 hours of the 
culture period. 5A9 T cells cocultured with HKLM and untreated 
macrophages incorporated 12,826 cpm. Data are the mean per-
centages of this control value, calculated from three identical wells. 
RESULTS 
FK 506, Cy A, or rapamycin-pretreated macrophages sup-
press the proliferative response of 5A9 T cells to HKLM. 
The proliferative response of 5A9 T cells to HKLM was 
significantly reduced when the cells were cocultured with 
macrophages pretreated with drug (Fig O. This inhibitory 
effect was dose-dependent. FK 506 was more potent than 
rapamycin which, in tum, was more potent than CyA. 
FK 506, Cy A, and rapamycin-pretreated macrophages 
suppress the blastogenic response of normal splenocytes 
to ConA. Studies were undertaken to determine whether 
the inhibitory effects of these drugs on T-cell proliferation 
were due to drug carryover rather than on the capacity of 
macrophages to process and/or present antigen. Macro-
phages were incubated with various concentrations of 
each drug as above. The cell monolayer was then washed 
four times, and normal splenocytes and ConA (a stimulant 
that induces T-cell proliferation independently of our drug-
treated macrophages of interest) were then added. T-cell 
proliferation was measured as previously. A significant 
suppression of the T-cell response to ConA was seen when 
cells were cocultured with macrophages pretreated with 
drug (Fig 2). This effect was much more pronounced with 
FK 506 than with rapamycin. In the case of CyA, appre-
ciable impairment was only found in cocultures containing 
macrophages preexposed to 1,000 nm. These data demon-
strate that the diminished proliferative response of 5A9 T 
lymphocytes to HKLM observed in cocultures containing 
macrophages pretreated with drug was mainly due to drug 
carry over rather than the effect of the drug on antigen 
processing and/or presentation. 
COOPER, GREGORY, THOMSON ET AL 
100 
80 
..J 
0 
II: 60 
!z 
a 
0 
u. 40 
0 
it 
20 
CONCENTRATION (nM) 
Fig 2. ConA response of normal splenocytes is suppressed in 
cocultures containing drug-pretreated macrophages. Normal sple-
nocytes and ConA (2 I-LQ/mL) were cocultured with bone marrow-
derived macrophages pretreated with drug at the concentrations 
indicated. Cell proliferation was assessed by tritiated thymidine 
incorporation during the last 18 hours of the culture period. 
ConA-stimulated splenocytes cocultured with untreated macro-
phages incorporated 16,325 cpm. All values are the mean per-
centages of this control value calculated from three identical wells. 
DISCUSSION 
The incubation of HKLM and 5A9 T cells with drug-
pretreated, macrophages resulted in significant suppres-
sion of antigen-induced T-cell proliferation. This suppres-
sion occurred regardless of whether macrophages were 
treated with FK 506, Cy A, or rapamycin. The nonspecific 
proliferation of splenocytes to ConA was also inhibited in 
cocultures containing drug-treated macrophages indicating 
our inability to wash drug from out of our system. 
Our results confirm previous studies by others in which 
a significant suppression of the T-cell response to antigen 
was observed when the cells were co cultured with macro-
phages pretreated with CyA. 2 These latter studies, how-
ever, gave little credence to the possibility of drug carry 
over. 
We are currently exploring alternative methods of wash-
ing drug-treated macrophages, in an effort to eliminate the 
direct effect of drug carry over on T-cell function. The 
development of such methodology would then enable us to 
assess the effects of immunosuppressants on the ability of 
macrophages to process or present antigen to T cells. 
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